Labels on Patanjali's two sharbat products, earmarked to be sold within India, were found to be having "additional medicinal and dietary market claims" as compared to the ones on bottles set aside for export to America, according to the US health regulator.
“Firm has separate production and packaging areas for exported and domestic products.”The United States and Food and Drug Administration (USFDA) report.


